{"nctId":"NCT02932306","briefTitle":"Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris","startDateStruct":{"date":"2015-11-03","type":"ACTUAL"},"conditions":["Acne"],"count":820,"armGroups":[{"label":"IDP-121 Lotion","type":"EXPERIMENTAL","interventionNames":["Drug: IDP-121 Lotion"]},{"label":"IDP-121 Vehicle Lotion","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: IDP-121 Vehicle Lotion"]}],"interventions":[{"name":"IDP-121 Lotion","otherNames":[]},{"name":"IDP-121 Vehicle Lotion","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Key Inclusion Criteria:\n\n* Male or female at least 9 years of age and older.\n* Written and verbal informed consent must be obtained. Participants less than age of consent must sign an assent for the study and a parent or a legal guardian must sign the informed consent (if participant reaches age of consent during the study they should be re-consented at the next study visit).\n* Participant must have a score of 3 (moderate) or 4 (severe) on the EGSS assessment at the screening and baseline visit\n\nKey Exclusion Criteria:\n\n* Use of an investigational drug or device within 30 days of enrollment or participation in a research study concurrent with this study.\n* Any dermatological conditions on the face that could interfere with clinical evaluations such as acne conglobata, acne fulminans, secondary acne, perioral dermatitis, clinically significant rosacea, gram-negative folliculitis.\n* Any underlying disease(s) or some other dermatological condition of the face that requires the use of interfering topical or systemic therapy or makes evaluations and lesion count inconclusive.\n* Participants with a facial beard or mustache that could interfere with the study assessments.","healthyVolunteers":false,"sex":"ALL","minimumAge":"9 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Absolute Change From Baseline in Mean Noninflammatory Lesion Count to Week 12","description":"Noninflammatory lesions were defined as follows: Open comedones (blackhead) - plugged hair follicle with dilated/open orifice, black in color; and Closed comedones (whitehead) - plugged hair follicle: small opening at skin surface. For noninflammatory facial lesions, open and closed comedones were recorded as a single count.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.8","spread":"15.18"},{"groupId":"OG001","value":"-10.6","spread":"16.07"}]}]}]},{"type":"PRIMARY","title":"Absolute Change From Baseline in Mean Inflammatory Lesion Count to Week 12","description":"Inflammatory lesions were defined as follows: Papule - a solid, elevated lesion less than 5 millimeters (mm); and Pustule - an elevated lesion containing pus less than 5 mm. For inflammatory facial lesions, papules and pustules were recorded as a single count, while nodular lesions were counted and recorded separately.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.1","spread":"10.50"},{"groupId":"OG001","value":"-10.2","spread":"10.87"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants With Treatment Success at Week 12","description":"Treatment success was defined as at least a 2-grade reduction from Baseline in EGSS score and an EGSS score equating to \"Clear\" or \"Almost Clear\". EGSS was based on a 5-point scale ranging from 0 to 4; where 0 = clear, 1 = almost clear, 2 = mild, 3 = moderate, and 4 = severe.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.5","spread":null},{"groupId":"OG001","value":"6.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Noninflammatory Lesion Count to Week 12","description":"Noninflammatory lesions were defined as follows: Open comedones (blackhead) - plugged hair follicle with dilated/open orifice, black in color; and Closed comedones (whitehead) - plugged hair follicle: small opening at skin surface. For noninflammatory facial lesions, open and closed comedones were recorded as a single count.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.5","spread":"41.92"},{"groupId":"OG001","value":"-27.3","spread":"43.96"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Inflammatory Lesion Count to Week 12","description":"Inflammatory lesions were defined as follows: Papule - a solid, elevated lesion less than 5 millimeters (mm); and Pustule - an elevated lesion containing pus less than 5 mm. For inflammatory facial lesions, papules and pustules were recorded as a single count, while nodular lesions were counted and recorded separately.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-50.9","spread":"40.72"},{"groupId":"OG001","value":"-40.4","spread":"42.29"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":378},"commonTop":[]}}}